Reviono, R. (2023) “Effectiveness of Zingiber officinale to reduce inflammation markers and the length of stay of patients with community-acquired pneumonia: An open-label clinical trial”, Narra J, 3(1), p. e142. doi: 10.52225/narra.v3i1.142.